The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
K Rudolf, Henri Doods, Wolfgang Eberlein(Pharmazeutische Fabrik Dr. Reckeweg (Germany)), Wolfhard Engel(Pharmazeutische Fabrik Dr. Reckeweg (Germany)), H. Wieland(Pharmazeutische Fabrik Dr. Reckeweg (Germany)), Klaus D. Willim(Pharmazeutische Fabrik Dr. Reckeweg (Germany)), Michael Entzeroth(Pharmazeutische Fabrik Dr. Reckeweg (Germany)), Wolfgang Wienen(Pharmazeutische Fabrik Dr. Reckeweg (Germany)), Annette G. Beck‐Sickinger(Leipzig University of Applied Sciences)
Cited by 374
Related Papers
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
|Pharmacological Reviews|1998|893
GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin
|Endocrinology|2006|432
Herbal drugs and phytopharmaceuticals
|Pharmaceutica Acta Helvetiae|1995|415
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Peptide chemistry toolbox – Transforming natural peptides into peptide therapeutics
|Bioorganic & Medicinal Chemistry|2018|320